Promosome is a San Diego- and New York-based biotechnology company that provides technical platforms for enhancing both yield and quality in the production of biotherapeutic and industrial proteins. The technology is based on the discoveries of Promosome CSO Dr. Vincent P. Mauro and the late Nobel Laureate Dr. Gerald M. Edelman of The Scripps Research Institute (TSRI) in La Jolla, California. Leveraging their expertise in the area of mRNA translation resulted in pioneering technologies that Promosome licenses to companies seeking to improve biotherapeutic and bioindustrial protein expression. Promosome’s technologies do not rely on codon optimization strategies. Thus they minimize the risk of negative clinical outcomes associated with synonymous mutations introduced in all codon optimization paradigms.